Objective To explore the feasibility of 11C-AZD9291 as a Micro PET-CT tracer for the detection of EGFR 19del mutation in lung cancer at the level of experimental animals. Methods The normal Kunming mice were injected with 11C-AZD9291 via tail vein, and were executed at different time points. The radioactive counting (%ID/g) was calculated for multiple organs of the mice. Lung adenocarcinoma cell lines HCC827 (EGFR 19del mutation) and A549 (EGFR wild-type) were used to construct the nude mouse models of lung cancer. Six eligible nude mice with HCC827 tumor were selected, and were divided into experimental group and blocking group. In the experimental group, 11C-AZD9291 was injected into the tail vein. The blocking group was injected with erlotinib and 11C-AZD9291 simultaneously. Other three nude mice transplanted with A549 was injected 11C-AZD9291 via tail vein as EGFR wildtype control group. After 20min, animal in-vivo imaging and analysis were performed by micro-pet (Explore Vista, GE). The independent-samples T test and one way ANOVA were used for statistical analysis. Results Kunming mice had the highest radiation uptake rate of 11C-AZD9291 in the liver, followed by kidney and lung. The radiation uptake rate in each organ at time point of 5min was higher than that at 15min (P < 0.05). And the radiation uptake rate in experiment group was higher than that in blocking group or control group. Conclusions At the level of experimental animals, 11C-AZD9291 is a good specific molecular probe for the detection of EGFR 19del mutation in lung cancer.